Naoto Kamiya
Papers
1
Total Citations
8
H-Index
1
About
Naoto Kamiya is a leading Japanese urological researcher whose work centers on optimizing treatment strategies for early-stage prostate cancer, with a particular emphasis on cost-effectiveness and patient-centered outcomes. His most impactful contribution comes from the PRIAS-JAPAN study, where he conducted a landmark comparative analysis of medical costs between active surveillance and standard treatments—including robot-assisted laparoscopic prostatectomy, brachytherapy, and intensity-modulated radiation therapy—for low-risk prostate cancer. This 2022 study, which has garnered 8 citations, provides critical evidence that active surveillance is not only clinically appropriate but also significantly more economical, potentially reducing unnecessary healthcare expenditures and overtreatment. Kamiya’s research bridges the gap between clinical efficacy and economic sustainability, offering actionable insights for urologists and health policymakers. His work is particularly notable for its focus on the Japanese healthcare system, addressing region-specific challenges in prostate cancer management. By quantifying the financial burden of aggressive treatments versus surveillance, Kamiya has contributed to a paradigm shift in how low-risk prostate cancer is approached, empowering patients and clinicians to make more informed, value-based decisions.
Research Focus
Key Achievements
Top Papers
- 1